跳至主要内容
临床试验/NCT01104012
NCT01104012已完成不适用

The VAPARA Study: Validation of Proteomic Analyses for Allergic Asthma and Rhinitis

Centre Hospitalier Universitaire de Nīmes3 个研究点 分布在 1 个国家目标入组 133 人开始时间: 2010年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
133
试验地点
3
主要终点
Proteomic profile of each patient

研究概览

简要总结

The purpose of this study is to verify and validate the intrinsic diagnostic value in terms of sensitivity and specificity of proteomic profiles determined during a pre-study for discriminating between allergy related asthma and allergy related rhinitis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed consent
  • never-smokers or non-smoking for at least 2 years + < 5 packs per year
  • capable of understanding the study
  • patient is affiliated with a social security system
  • positive skin tests (at least one for Montpellier region pneumoallergens)
  • treated with nasal or inhaled corticoids, leucotriene receptor antagonists, anti-IgE, Theophylline, anti-histamines, sodium cromoglycate, beta-blockers, benzodiazépine, oral corticoids: all these treatments must be interrupted for at least 72 hours

排除标准

  • Co-morbidities: none; no co-morbidities are accepted
  • dental infections (any) during the 3 months preceding the study
  • suspected alcoholism or drug abuse
  • chronic viral infection (hepatitis, HIV)
  • patient under guardianship

结局指标

主要结局

Proteomic profile of each patient

时间窗: One day (snapshot)

The attribution of a proteomic profile as either "asthmatic" or "rhinitis". Proteomic profiles are determined accordig to the SELDI-TOF method. This is a transversal study validating proteomic profiles as a new diagnostic test.

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验